Description
About the Author
Luc Friboulet, PhD, is ERC Principal Investigator and INSERM team leader at Gustave Roussy cancer campus. He studies the tumor adaptation to kinase inhibitors. Linked to a clinical trial named MATCH-R allowing collection of repeated biopsies in patients treated with ALK, ROS1, RET, EGFR, BRAF, FGFR inhibitors Dr. Friboulet characterizes the resistance mechanisms and establishes new laboratory models.
Reviews
"This book is a valuable resource for cancer researchers, clinicians and several members of biomedical field who need to understand more about how to fight ALK resistance in cancer treatment." --Anticancer Research
Book Information
ISBN 9780128217740
Author Luc Friboulet
Format Hardback
Page Count 216
Imprint Academic Press Inc
Publisher Elsevier Science Publishing Co Inc
Weight(grams) 630g